What are the appropriate admission orders for a patient with hepatic encephalopathy and hyperammonemia?

Admission Orders for Hepatic Encephalopathy and Hyperammonemia

Start lactulose 30-45 mL (20-30 g) orally every 1-2 hours immediately until the patient achieves at least 2 bowel movements per day, then titrate to 2-3 soft stools daily; add rifaximin 550 mg twice daily for faster recovery and shorter hospital stays. 1

Initial Stabilization and Assessment

Upon admission, immediately:

• Establish IV access and start dextrose-containing fluids at high infusion rate to prevent catabolism
• Stop all protein intake temporarily (maximum 48 hours)
• Intubate and ventilate if West-Haven grade 3-4 or unable to protect airway
• Monitor vital signs continuously with ICU-level care for grade ≥3 encephalopathy 2
• Check blood glucose frequently and maintain normoglycemia

Laboratory Orders

Immediate labs:

• Ammonia level (venous or arterial blood in lithium heparin/EDTA tube, transported on ice, processed within 15 minutes) 3
• Complete metabolic panel with attention to sodium, potassium, creatinine
• Liver function tests, PT/INR
• Complete blood count
• Blood cultures if infection suspected
• Arterial blood gas (look for respiratory alkalosis suggesting hyperammonemia) 4

Monitor ammonia every 3 hours initially until trending down 3

Critical caveat: A normal ammonia level essentially rules out hepatic encephalopathy and should prompt immediate search for alternative diagnoses 5. However, elevated ammonia alone does not confirm HE—clinical correlation is essential.

Pharmacological Management

First-Line Therapy (All Patients)

Lactulose dosing by severity:

• Mild-moderate (Grade 1-2): 30-45 mL (20-30 g) orally every 1-2 hours until ≥2 bowel movements, then 20-30 g three to four times daily 1
• Severe (Grade ≥3) or unable to take PO:
  • Nasogastric tube administration, OR
  • Lactulose enema: 300 mL lactulose + 700 mL water, 3-4 times daily, retain ≥30 minutes 1

Goal: 2-3 soft stools per day (not diarrhea)

Add-On Therapy for Enhanced Recovery

Rifaximin 550 mg PO twice daily (or 400 mg three times daily) 1

The combination of lactulose plus rifaximin demonstrates superior outcomes compared to lactulose alone: 76% vs 44% recovery within 10 days (P=0.004) and 5.8 vs 8.2 day hospital stays (P=0.001) 1. This represents the strongest evidence for combination therapy.

Limitation: Rifaximin requires oral/NG administration, limiting use in grade 4 encephalopathy 1

Additional Adjunctive Therapies

Consider adding based on severity:

For Grade 1-2 encephalopathy:

• IV L-ornithine-L-aspartate (LOLA) 30 g/day: Faster symptom recovery (1.92 vs 2.50 days, P=0.002) when combined with lactulose 1

For all grades:

• IV albumin 1.5 g/kg/day until clinical improvement or maximum 10 days: Improves recovery rate (75% vs 53.3%, P=0.03) 1
• Oral BCAAs 0.25 g/kg/day: Ancillary benefit for overt HE 1

Alternative to lactulose (if intolerant):

• Polyethylene glycol 4 liters orally over 4 hours: Superior 24-hour improvement in one RCT but requires further validation 1

Identify and Treat Precipitating Factors

Systematically evaluate and address:

• GI bleeding: Check hemoglobin, perform EGD if indicated, transfuse as needed 1
• Infection: Blood/urine cultures, chest X-ray, diagnostic paracentesis if ascites present; start empiric antibiotics if suspected
• Constipation: Aggressive bowel regimen with lactulose/enemas 1
• Dehydration/renal dysfunction: Check BUN/creatinine, stop or reduce diuretics, give IV fluids (albumin preferred) 1
• Hyponatremia: Target sodium >130 mmol/L (ideally >135 mmol/L); adjust diuretics 6
• Hypokalemia: Correct aggressively; stop/reduce diuretics 1
• Medications: STOP benzodiazepines (give flumazenil if recent use), opioids (give naloxone), and unnecessary PPIs 1, 6
• Excessive protein intake: Temporarily restrict but resume within 48 hours once ammonia normalizes 3

Controlling precipitating factors alone leads to improvement in ~90% of cases 2.

Medications to AVOID

Never use:

• Neomycin (nephrotoxicity, ototoxicity)
• Metronidazole (peripheral neuropathy) 1
• Benzodiazepines (contraindicated in decompensated cirrhosis) 6

Monitoring Orders

• Neurological checks every 2-4 hours using West-Haven criteria
• Ammonia levels: Every 3 hours initially, then daily once improving 3
• Electrolytes: Daily, more frequently if abnormal
• Stool frequency: Document to ensure 2-3 soft stools daily
• Fluid balance: Strict intake/output

Imaging

Brain CT or MRI indicated if:

• Diagnostic uncertainty
• Focal neurological signs
• No response to standard therapy within 48-72 hours
• History of alcohol use (increased intracerebral bleeding risk) 5

Important: No imaging findings are diagnostic of HE; imaging is for excluding alternative diagnoses 5

Escalation Criteria

Consider dialysis/CKRT if: 3

• Ammonia >400 μmol/L refractory to medical therapy
• Rapid rise to >300 μmol/L within hours
• Ammonia >150 μmol/L with rapidly deteriorating neurological status, coma, or cerebral edema
• Grade 3-4 encephalopathy not responding to maximal medical therapy

High-dose CVVHD (blood flow 30-50 mL/min, dialysate/blood flow ratio >1.5) is preferred modality 3

Liver transplantation evaluation for:

• Recurrent intractable overt HE
• Severe HE unresponsive to medical treatment 1
• Acute liver failure with HE 1

Nutritional Orders

• Stop protein temporarily on admission (maximum 48 hours)
• Resume protein at 0.8-1.2 g/kg/day once ammonia <100 μmol/L and mental status improving
• High-calorie dextrose infusion to prevent catabolism
• Consider BCAA supplementation 0.25 g/kg/day 1

Disposition Planning

Before discharge ensure:

• Mental status returned to baseline
• Ammonia normalized or near-normal
• Established on maintenance lactulose (titrated to 2-3 soft stools daily)
• Rifaximin 550 mg twice daily for secondary prophylaxis 1
• Precipitating factors addressed
• Patient/family education on medication adherence and early warning signs